心泰医疗港股暴涨约47% 多只A股基金“曲线持仓”

Group 1 - The core viewpoint of the article highlights the significant surge in the stock price of HeartTech Medical, which rose approximately 47% on the Hong Kong stock market [1] - HeartTech Medical is a subsidiary of Lepu Medical, which is listed on the A-share market, and is heavily held by Southern Fund and certain A-share funds under Huatai PineBridge [1] - The financial report for the fiscal year 2024 indicates that HeartTech Medical achieved a revenue of 466 million yuan, representing a year-on-year growth of 44.78%, and a net profit attributable to the parent company of 246 million yuan, reflecting a year-on-year increase of 62.22% [1]